Ajanta Pharma bonus shares and stock split history
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Last close ₹3,283.90up ₹13.30 (0.41%)BSE ₹3,281.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹3,270.60.
52-week range of traded prices to 23 Oct 2026
₹2,382.00Low, 28 Oct 2025₹3,796.00High, 18 Aug 2026
- Next results date: the board meets on 30 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹41,035 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 Jul 2026
- 36.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 5 May 2026
- 9.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.83%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 30 Jul 2026
- 27.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 30 Jul 2026
- 27.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 5 May 2026
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,54,84762.5% delivered
What one share became
Bonus issues and splits since Jan 2007. Neither changes what a holding is worth on the day.Ajanta Pharma dividend history
One share held before 9 Aug 201211.25 shares todayShares today for one share held before. One share multiplied by the share factor of this bonus or split and of every one after it: a 1:1 bonus doubles the count, and a split of a ₹10 share into ₹2 shares multiplies it by five.
- Face value today
- ₹2
- Bonus issues
- 2
- Splits
- 2
Bonus issues: ratio, ex-date and record date
A bonus issue gives holders free extra shares in a fixed ratio. On record from 2007.
Shares today for one held before the ex-date, after every event sinceShares today for one share held before. One share multiplied by the share factor of this bonus or split and of every one after it: a 1:1 bonus doubles the count, and a split of a ₹10 share into ₹2 shares multiplies it by five.
- 22 Jun 2022 · ex-date1 for 2 bonusRecord date 23 Jun 20221.50 shares todayfor 1 held before 22 Jun 2022
- 17 Sep 2013 · ex-date1 for 2 bonusRecord date 18 Sep 20135.63 shares todayfor 1 held before 17 Sep 2013
Stock splits: face value, ex-date and record date
A stock split, or share split, divides each share into more shares of a lower face value. On record from 2007.
Shares today for one held before the ex-date, after every event sinceShares today for one share held before. One share multiplied by the share factor of this bonus or split and of every one after it: a 1:1 bonus doubles the count, and a split of a ₹10 share into ₹2 shares multiplies it by five.
- 20 Mar 2015 · ex-dateEvery 2 shares became 5, face value ₹5 to ₹2Record date 23 Mar 20153.75 shares todayfor 1 held before 20 Mar 2015
- 9 Aug 2012 · ex-dateEach share became 2, face value ₹10 to ₹5Record date 10 Aug 201211.25 shares todayfor 1 held before 9 Aug 2012
Buybacks
Every one on record, latest first.
- Buyback · 30 May 2024 · record date 30 May 2024Tender offer to holders on the record date at ₹2,770 a share for 10,28,881 shares, open 5 Jun 2024 to 11 Jun 2024. Holders tendered 58.85 times the shares on offer.
- Buyback · 24 Mar 2023 · record date 24 Mar 2023Tender offer to holders on the record date at ₹1,425 a share for 22,10,500 shares, open 31 Mar 2023 to 10 Apr 2023. Holders tendered 29.08 times the shares on offer.
- Buyback · 13 Jan 2022 · record date 14 Jan 2022Tender offer to holders on the record date at ₹2,550 a share for 11,20,000 shares, open 3 Feb 2022 to 16 Feb 2022. Holders tendered 20.04 times the shares on offer.
- Buyback · 12 Nov 2020 · record date 13 Nov 2020Tender offer to holders on the record date at ₹1,850 a share for 7,35,000 shares, open 3 Dec 2020 to 16 Dec 2020. Holders tendered 19.22 times the shares on offer.
- Buyback · 11 Feb 2019 · record date 12 Feb 2019Tender offer to holders on the record date at ₹1,300 a share, open 28 Feb 2019 to 14 Mar 2019.